The US will exempt select Indian specialty drugs and their ingredients from a new 100% pharma tariff. Here’s what products qualify and why.

Shares of Summit Therapeutics Inc. (NASDAQ: SMMT) surged about 20% premarket on Tuesday after AstraZeneca Plc (NYSE: AZN) ...

AstraZeneca invests $2b in Summit Therapeutics to boost cancer drug development and explore new treatment combinations.

US has expempted select speciality medications and related components from India and 19 partner jurisdictions from import duties ...

AstraZeneca PLC (LSE:AZN, NASDAQ:AZN), the FTSE 100 pharmaceutical company, will invest $2 billion in Summit Therapeutics Inc ...

AstraZeneca (AZN) has made a strategic equity investment of $2 billion in anti-cancer drug developer Summit Therapeutics ...

AstraZeneca ( AZN) has agreed to make a $2 billion strategic equity investment in Summit Therapeutics ( SMMT) while launching a clinical collaboration aimed at advancing new cancer treatment ...

AbClon said partner Henlius expanded clinical programs for HER2 antibody AC101 to nine, adding a Phase 2 colorectal cancer ...

The pharmaceutical giant said 11 of the presentations will be oral sessions at the October 23-27 ESMO Congress in Madrid ...

Summit Therapeutics said on Monday that British drugmaker AstraZeneca would invest $2 billion in ​the company and collaborate ...

Daiichi Sankyo and Merck & Co (MSD) have voluntarily withdrawn their biologics license application (BLA) for ifinatamab deruxtecan, aimed at treating adult patients with extensive-stage small cell ...

HUTCHMED (China) Limited (“ HUTCHMED ” or the “Company”) (Nasdaq/AIM:HCM; HKEX:13) today announces that it has initiated the Phase Ia part of a global clinical trial of HMPL-A830 in patients with ...